Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps
Advanced Science · 2023
DOI: 10.1002/advs.202205105 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, 2023. Verfasst von Sean T Carey und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Maryland Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA. Hauptthemen laut MEDLINE: Biocompatible Materials, Hypersensitivity. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Autoimmunity and allergies affect a large number of people across the globe. Current approaches to these diseases target cell types and pathways that drive disease, but these approaches are not cures and cannot differentiate between healthy cells and disease‐causing cells. New immunotherapies that induce potent and selective antigen‐specific tolerance is a transformative goal of emerging treatments for autoimmunity and serious allergies. These approaches offer the potential of halting—or even reversing—disease, without immunosuppressive side effects. However, translating successful induction of tolerance to patients is unsuccessful. Biomaterials offer strategies to direct and maximize immunological mechanisms of tolerance through unique capabilities such as codelivery of small molecules or signaling molecules, controlling signal density in key immune tissues, and targeting. While a growing body of work in this area demonstrates success in preclinical animal models, these therapies are only recently being evaluated in human trials. This review will highlight the most recent advances in the use of materials to achieve antigen‐specific tolerance and provide commentary on the current state of the clinical development of these technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Maryland Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.
- US Department of Veterans Affairs, VA Maryland Health Care System, Baltimore, MD, 21201, USA.
- Robert E. Fischell Institute for Biomedical Devices, College Park, MD, 20742, USA.
- Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, MD, 21201, USA.
- Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, 21201, USA.
ORCID-Profile: Christopher M Jewell
Förderung
- BLRD VA
- NIH HHS
- NIAID NIH HHS
- United States Department of Veterans Affairs
- National Institute of Health Training
- NIBIB NIH HHS
- National Institutes of Health
Zitieren
APA
Carey, S. T., Bridgeman, C., & Jewell, C. M. (2023). Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps. Advanced Science. https://doi.org/10.1002/advs.202205105
Vancouver
Carey ST, Bridgeman C, Jewell CM. Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps. Advanced Science. 2023. doi:10.1002/advs.202205105
BibTeX
@article{Carey2023,
author = {Carey, Sean T and Bridgeman, Christopher and Jewell, Christopher M},
title = {Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202205105}
}
EUVIMED